182 related articles for article (PubMed ID: 24295857)
1. Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.
Jiang Y; Osgood N; Lim HJ; Stang MR; Dyck R
CMAJ; 2014 Feb; 186(2):103-9. PubMed ID: 24295857
[TBL] [Abstract][Full Text] [Related]
2. The long-term risks of end stage renal disease and mortality among First Nations and non-First Nations people with youth-onset diabetes.
Dyck RF; Jiang Y; Osgood ND
Can J Diabetes; 2014 Aug; 38(4):237-43. PubMed ID: 24986804
[TBL] [Abstract][Full Text] [Related]
3. Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.
Gao A; Osgood ND; Jiang Y; Dyck RF
BMC Nephrol; 2017 Sep; 18(1):283. PubMed ID: 28870154
[TBL] [Abstract][Full Text] [Related]
4. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
5. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.
Dyck RF; Tan L
CMAJ; 1994 Jan; 150(2):203-8. PubMed ID: 8287342
[TBL] [Abstract][Full Text] [Related]
6. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.
Nelson RG; Knowler WC; McCance DR; Sievers ML; Pettitt DJ; Charles MA; Hanson RL; Liu QZ; Bennett PH
Diabetologia; 1993 Oct; 36(10):1087-93. PubMed ID: 8243859
[TBL] [Abstract][Full Text] [Related]
7. Differences in glycemic control and survival predict higher ESRD rates in diabetic First Nations adults.
Dyck RF; Sidhu N; Klomp H; Cascagnette PJ; Teare GF
Clin Invest Med; 2010 Dec; 33(6):E390-7. PubMed ID: 21134341
[TBL] [Abstract][Full Text] [Related]
8. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
Harding JL; Morton JI; Shaw JE; Patzer RE; McDonald SP; Magliano DJ
Nephrol Dial Transplant; 2022 Sep; 37(10):2004-2013. PubMed ID: 34724066
[TBL] [Abstract][Full Text] [Related]
9. Tracking ancient pathways to a modern epidemic: diabetic end-stage renal disease in Saskatchewan aboriginal people.
Dyck RF
Kidney Int Suppl; 2005 Aug; (97):S53-7. PubMed ID: 16014101
[TBL] [Abstract][Full Text] [Related]
10. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
Lim HJ; Zhang X; Dyck R; Osgood N
BMC Med Res Methodol; 2010 Oct; 10():97. PubMed ID: 20964855
[TBL] [Abstract][Full Text] [Related]
11. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease.
Villar E; Polkinghorne KR; Chang SH; Chadban SJ; McDonald SP
Diabetologia; 2009 Dec; 52(12):2536-41. PubMed ID: 19756481
[TBL] [Abstract][Full Text] [Related]
12. Quality of care for First Nations and non-First Nations People with diabetes.
Deved V; Jette N; Quan H; Tonelli M; Manns B; Soo A; Barnabe C; Hemmelgarn BR;
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1188-94. PubMed ID: 23449766
[TBL] [Abstract][Full Text] [Related]
13. Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): An Emerging Relationship With Pregestational Diabetes Mellitus Among First Nations and Non-First Nations People in Saskatchewan-Results From the DIP: ORRIIGENSS Project.
Dyck RF; Karunanayake C; Pahwa P; Stang M; Erickson RL; Osgood ND
Can J Diabetes; 2021 Jun; 45(4):346-354.e1. PubMed ID: 33308984
[TBL] [Abstract][Full Text] [Related]
14. Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with Type 2 diabetes.
Liu JJ; Lim SC; Yeoh LY; Su C; Tai BC; Low S; Fun S; Tavintharan S; Chia KS; Tai ES; Sum CF
Diabet Med; 2016 Mar; 33(3):332-9. PubMed ID: 26514089
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus.
Thakar CV; Christianson A; Himmelfarb J; Leonard AC
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2567-72. PubMed ID: 21903988
[TBL] [Abstract][Full Text] [Related]
16. Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995-2014: a population-based study using linked administrative data.
Walker JD; Slater M; Jones CR; Shah BR; Frymire E; Khan S; Jacklin K; Green ME
CMAJ; 2020 Feb; 192(6):E128-E135. PubMed ID: 32041696
[TBL] [Abstract][Full Text] [Related]
17. Placing Aboriginal kidney disease in context.
McDonald SP
CMAJ; 2014 Feb; 186(2):93-4. PubMed ID: 24295866
[No Abstract] [Full Text] [Related]
18. Lifetime risk of diabetes among First Nations and non-First Nations people.
Turin TC; Saad N; Jun M; Tonelli M; Ma Z; Barnabe CCM; Manns B; Hemmelgarn B
CMAJ; 2016 Nov; 188(16):1147-1153. PubMed ID: 27647609
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death.
Joshy G; Dunn P; Fisher M; Lawrenson R
Diabetologia; 2009 Aug; 52(8):1474-8. PubMed ID: 19436991
[TBL] [Abstract][Full Text] [Related]
20. Diabetes prevalence rates among First Nations adults on Saskatchewan reserves in 1990: comparison by tribal grouping, geography and with non-First Nations people.
Pioro MP; Dyck RF; Gillis DC
Can J Public Health; 1996; 87(5):325-8. PubMed ID: 8972968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
